Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset
about
Levodopa-Induced Dyskinesia Is Related to Indirect Pathway Medium Spiny Neuron Excitotoxicity: A Hypothesis Based on an Unexpected FindingCOMT Val158Met Polymorphism Modulates Huntington's Disease Progression.Challenges of Huntington's disease and quest for therapeutic biomarkers.Psychiatric and cognitive symptoms in Huntington's disease are modified by polymorphisms in catecholamine regulating enzyme genes.
P2860
Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington's disease motor onset
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Candidate glutamatergic and do ...... ntington's disease motor onset
@ast
Candidate glutamatergic and do ...... ntington's disease motor onset
@en
type
label
Candidate glutamatergic and do ...... ntington's disease motor onset
@ast
Candidate glutamatergic and do ...... ntington's disease motor onset
@en
prefLabel
Candidate glutamatergic and do ...... ntington's disease motor onset
@ast
Candidate glutamatergic and do ...... ntington's disease motor onset
@en
P2093
P2860
P50
P1433
P1476
Candidate glutamatergic and do ...... ntington's disease motor onset
@en
P2093
Andrea Zanko
Diane Lucente
Eliana Marisa Ramos
Elizabeth McCusker
Estrella Gomez-Tortosa
Herminia D Rosas
Jayalakshmi S Mysore
Jeanne C Latourelle
Jong-Min Lee
Karen Marder
P2860
P2888
P304
P356
10.1007/S10048-013-0364-Y
P50
P577
2013-05-04T00:00:00Z